Highlights

• Revenue rose 7% to $12.3 million; gross Margin before amortization improved to 46% from 39%

• Adjusted EBITDA reached $2.0 million versus $0.5 million a year earlier; Net Income was $0.4 million

• Sales order Backlog of $21.6 million, cash of $12.2 million, no debt, and a letter of Credit Facility extended to September 30, 2027

Greenlane Renewables Inc. (TSX:GRN), a Canadian supplier of systems that clean and upgrade biogas into renewable natural gas, published its third quarter financial results in a release issued after the close last Thursday. The report describes a quarter in which revenue grew modestly, margins widened and adjusted EBITDA reached the second highest level in company history. Management characterised the period as on track with its strategic plan, which centres on profitable product lines and a new generation of equipment.

Margins Do the Heavy Lifting

Revenue from continuing operations rose by about seven percent to roughly twelve and a third million dollars. The more telling movement came in profitability. Gross margin before amortization reached the mid-forties as a percentage of revenue, up from the high thirties a year earlier, and adjusted EBITDA climbed to about two million dollars from roughly half a million dollars in the prior-year quarter. Net income and comprehensive income from continuing operations was about four hundred thousand dollars, which is a small figure but a clear improvement on last year.

The explanation lies in mix. Parts and service revenue jumped by more than half to roughly five million dollars, helped by a significant order from an existing customer that develops renewable Natural Gas projects in the United States. Sales of biogas desulfurization systems, built in Italy and delivered worldwide through the Wholly Owned Subsidiary Airdep, also contributed. The company describes parts, service and desulfurization as its most profitable areas, so a heavier weighting toward them lifts margins even when total revenue grows slowly.

Winding Down the Legacy Book

Sales of biogas upgrading systems declined during the period, partly because three contracts were completed and released about seven tenths of a million dollars of project contingency. That is consistent with the strategy described by chief executive Brad Douville: grow in the most profitable areas, wind down older low-margin upgrading contracts and ramp up the next-generation Cascade LF and Cascade MS product lines.

Such a transition has an unusual accounting shape. Revenue from legacy contracts is recognised over roughly nine to eighteen months, and some contracts allow termination, so quarterly revenue can swing widely. The company explicitly warns that its financial outlook is subject to that concentration in a small number of large orders. Operating expenses were lower in the quarter, although they benefited from capitalising about seven tenths of a million dollars of development spending after milestones were reached on the new product lines.

Backlog, Cash and Funding

The sales order backlog, which counts unrecognised revenue from system Supply contracts and excludes parts, service and Royalty income, stood at roughly twenty-two million dollars at the end of September. Orders announced during the quarter included a service work order and a desulfurization order from an existing United States customer, together worth about two and a half million dollars.

The Balance Sheet looks conservative. Cash was a little over twelve million dollars, and the company reports no Debt other than ordinary payables. A Standby Letter of Credit facility of twenty million dollars, supported by a guarantee from Export Development Canada, was extended to the end of September next year. Letter of credit capacity matters for equipment suppliers because customers frequently require performance guarantees before awarding contracts.

The Cascade Platform and Brazil

The strategic centrepiece is the Cascade family of compact biogas upgraders. According to the release, partner Panasonic is moving toward production readiness in Brazil by the end of this year, subject to permits. Upgrades to a factory are nearly complete, purchase orders have been issued for Manufacturing equipment and long-lead components for the first units, and hiring is under way.

Management says some Brazilian sales opportunities are in late stages, with quoting having started about a year ago after the product reveal. Sales cycles in this field typically run from one to two years, so revenue from the new lines is a medium-term prospect rather than an immediate one. Readiness to serve North America is expected next year. The company sizes the annual addressable market across Brazil, the United States and Canada at more than a billion dollars, and argues that local manufacturing in Brazil helps customers avoid Import tariffs and secure attractive project financing. Readers following Smallcap Stocks will recognise the pattern of a small company relying on a large partner to scale a new product.

Policy and Market Backdrop

Demand for renewable natural gas equipment depends heavily on government incentives and on the willingness of project developers to commit capital. When rules are unclear, developers tend to defer final Investment decisions, and equipment suppliers feel the delay first in their order books.

The release spends time on the policy environment, which shapes Demand for renewable natural gas. In North America, the American Biogas Council welcomed new guidance from the Internal Revenue Service on the clean fuel production credit, and the company says earlier uncertainty had delayed investment. In Europe, biomethane is framed as a strategic part of energy security and decarbonisation. In Brazil, infrastructure investment was volatile around the October presidential election, but the energy sector expects continued support for the energy transition after the re-election of the incumbent.

For Canadian observers, the company sits at the intersection of clean energy policy, agricultural and landfill waste streams and export markets. Domestic policy, including federal clean fuel incentives and provincial renewable gas programmes, influences sentiment, although the release itself focuses on foreign markets for growth.

Risks and What to Watch

The risk register is substantial. Product market acceptance for the new lines is unproven, converting backlog into revenue depends on project timing, and policy changes could alter project economics. Supply chain issues, competition and macroeconomic or geopolitical conditions also feature in the cautionary language, as does the assumption that Panasonic obtains its permits on time.

Developments worth monitoring include confirmation of production readiness in Brazil, the first orders for the Cascade LF and Cascade MS lines, the pace at which legacy contracts finish, and whether margins remain elevated once the mix normalises. Also relevant is how the company allocates its cash between development spending and the working Capital needed for larger systems.

Market Context

The company describes more than three and a half decades of activity and a large installed base spread across dozens of countries. That track record gives it credibility with customers, yet the Business remains small in absolute terms, so a handful of contracts can change reported results noticeably from one quarter to the next.

Greenlane trades on the Toronto Stock Exchange and is a small constituent of the broader Canadian listed universe far from the heavyweights of the [S&P/TSX Composite Index]. Shares of small Clean Technology companies often react strongly to order announcements and policy headlines, and trading volumes can be limited. The quarter delivers evidence that the profitability plan is working at the margin, while the larger test, converting the new product platform into steady orders, still lies ahead.